BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 35.23
-0.89 (-2.46%)
At close: Sep 11, 2026
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 15.33 billion as of September 11, 2026. Its market cap has decreased by -60.26% in one year.
Market Cap
15.33B
Enterprise Value
16.28B
Revenue
1.36B
Ranking
n/a
PE Ratio
151.92
Stock Price
35.23
ChartMarket Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 15.33B, an increase of 22.18%. That is a compound annual growth rate of 2.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 15.33B | -26.07% |
| Dec 31, 2025 | 20.74B | 62.70% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hebei Changshan Biochemical Pharmaceutical | 20.97B |
| Yili Chuanning Biotechnology | 19.02B |
| Sinocelltech Group | 15.68B |
| Acrobiosystems | 15.00B |
| Anhui Anke Biotechnology (Group) | 13.57B |
| Jinyu Bio-technology | 13.12B |
| HitGen | 12.53B |
| GemPharmatech | 12.51B |